Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2014; 20(44): 16726-16733
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16726
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16726
Figure 2 Percentage of patients with a sustained virologic response according to prior response to Peginterferon-α + Ribavirin treatment, level of fibrosis and viral load.
HCV: Hepatitis C virus; SVR: Sustained virological response.
- Citation: Bernabucci V, Ciancio A, Petta S, Karampatou A, Turco L, Strona S, Critelli R, Todesca P, Cerami C, Sagnelli C, Rizzetto M, Cammà C, Villa E. Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women. World J Gastroenterol 2014; 20(44): 16726-16733
- URL: https://www.wjgnet.com/1007-9327/full/v20/i44/16726.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i44.16726